top of page
Toremifene

托瑞米芬
Mechanism of action:
Toremifene 是一種選擇性雌激素受體調節劑(selective estrogen receptor modulator),屬於三苯乙烯類(triphenylethylene)衍生物。Toremifene 可拮抗乳腺細胞中的雌激素受體(estrogen receptor)ERα、ERβ,阻止內源性雌激素啟動與細胞增殖相關的基因轉錄,抑制 ER⁺ 乳癌細胞的生長與分裂。Toremifene 對於子宮內膜的 ERα、ERβ 受體則有輕微促效作用,可能刺激內膜增生。
Reference(s):
1. Price N et al. (2005). Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer. Clin Prostate Cancer.
2. Taneja SS et al. (2006). Toremifene--a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy. Expert Opin Investig Drugs.
3. Thompson IM et al. (2007). Chemoprevention of prostate cancer: agents and study designs. J Urol.
bottom of page
